(Q33834597)

29 July 2017

1 reference

title

Oxaliplatin: pharmacokinetics and chronopharmacological aspects (English)

1 reference

29 July 2017

1 reference

1 reference

Lévi F

1

1 reference

29 July 2017

Metzger G

series ordinal

2

1 reference

29 July 2017

Massari C

series ordinal

3

1 reference

29 July 2017

Milano G

series ordinal

4

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Clinical Pharmacokinetics

29 July 2017

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-21

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200038010-00001

29 July 2017

exact match

0 references

cites work

Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer

1 reference

12 December 2020

1,2-Diaminocyclohexane platinum derivatives of potential clinical value.

1 reference

12 December 2020

Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity

1 reference

12 December 2020

Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics

1 reference

12 December 2020

Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer

1 reference

12 December 2020

Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.

1 reference

12 December 2020

Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration

1 reference

12 December 2020

Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma

1 reference

12 December 2020

Pharmacokinetics of carboplatin after i.v. administration

1 reference

12 December 2020

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

1 reference

12 December 2020

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin

1 reference

12 December 2020

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin

1 reference

12 December 2020

Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.

1 reference

12 December 2020

Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers

1 reference

12 December 2020

Determination of unbound platinum after oxaliplatin administration: comparison of currently available methods and influence of various parameters

1 reference

12 December 2020

Circadian changes in estimated hepatic blood flow in healthy subjects

1 reference

12 December 2020

Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients

1 reference

12 December 2020

Intracellular glutathione and cytotoxicity of platinum complexes

1 reference

12 December 2020

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

12 December 2020

Circadian-system alterations during cancer processes: a review

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin

1 reference

12 December 2020

Clinical Pharmacokinetics of Carboplatin

1 reference

12 December 2020

Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing

1 reference

12 December 2020

Activity of oxaliplatin against human tumor colony-forming units.

1 reference

12 December 2020

Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity

1 reference

12 December 2020

Drugs five years later. Cisplatin

1 reference

12 December 2020

Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA.

1 reference

12 December 2020

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer

1 reference

12 December 2020

Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology

1 reference

12 December 2020

Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes

1 reference

12 December 2020

Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines

1 reference

12 December 2020

Antitumor activity of l-OHP in mice.

1 reference

12 December 2020

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

1 reference

12 December 2020

Differences between young and elderly subjects in seasonal and circadian variations of total plasma proteins and blood volume as reflected by hemoglobin, hematocrit, and erythrocyte counts

1 reference

12 December 2020

Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.

1 reference

12 December 2020

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronothe

1 reference

12 December 2020

Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones

1 reference

12 December 2020

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry

1 reference

12 December 2020

Biotransformations of oxaliplatin in rat blood in vitro

1 reference

12 December 2020

Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients

1 reference

12 December 2020

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

12 December 2020

Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits

1 reference

12 December 2020

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

12 December 2020

Kinetics of the reaction of cis-platinum compounds with DNA in vitro

1 reference

12 December 2020

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells

1 reference

12 December 2020

Pharmacokinetics and safety profile of oxaliplatin

1 reference

12 December 2020

Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice

1 reference

12 December 2020

Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion

1 reference

12 December 2020

[Phase I clinical study of oxaliplatin]

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin

1 reference

12 December 2020

Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing time

1 reference

12 December 2020

Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats

1 reference

12 December 2020

Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil

1 reference

12 December 2020

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

12 December 2020

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infus

1 reference

12 December 2020

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

1 reference

12 December 2020

Time dependency in plasmatic protein binding of cisplatin

1 reference

12 December 2020

Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).

1 reference

12 December 2020

Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients

1 reference

12 December 2020

Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.

1 reference

12 December 2020

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

12 December 2020

Clinical pharmacokinetics and dose optimisation of carboplatin.

1 reference

12 December 2020

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

12 December 2020

In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells

1 reference

12 December 2020

Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients

1 reference

12 December 2020

Modulation of nonprotein sulphydryl compounds rhythm with buthionine sulphoximine: relationship with oxaliplatin toxicity in mice

1 reference

12 December 2020

Circadian timing of cancer chemotherapy

1 reference

12 December 2020

High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin

1 reference

12 December 2020

Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form

1 reference

12 December 2020

Chronopharmacokinetics. Current status

1 reference

12 December 2020

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial

1 reference

12 December 2020

Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model.

1 reference

12 December 2020

Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats

1 reference

12 December 2020

Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes

1 reference

12 December 2020

Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice

1 reference

12 December 2020

Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin

1 reference

12 December 2020

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

12 December 2020

Oxaliplatin pharmacokinetics during a four-hour infusion

1 reference

12 December 2020

Circadian time dependence of cisplatin urinary kinetics

1 reference

12 December 2020

Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice

1 reference

12 December 2020

Clinical kinetics on intact cisplatin and some related species

1 reference

12 December 2020

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer

1 reference

12 December 2020

10.2165/00003088-200038010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1051695443

0 references

1 reference